{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "13",
                "@year": "2023",
                "@timestamp": "2023-07-13T07:27:47.000047-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2018",
                "@month": "09"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Janssen Research and Development, LLC",
                "xocs:funding-agency-acronym": "JRD",
                "xocs:funding-agency": "Janssen Research and Development",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005205",
                "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
            },
            "xocs:funding-addon-generated-timestamp": "2021-05-26T05:02:50.318Z",
            "xocs:funding-text": "This work was supported by Janssen Research and Development, LLC and co-funded by Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Austria",
                            "@afid": "60011394",
                            "@country": "aut",
                            "city": "Vienna",
                            "organization": [
                                {"$": "Medical University of Vienna"},
                                {"$": "Vienna General Hospital"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60011394"},
                                {"@afid": "60026929"}
                            ]
                        },
                        "author": [{
                            "ce:given-name": "Johannes",
                            "preferred-name": {
                                "ce:given-name": "Johannes",
                                "ce:initials": "J.",
                                "ce:surname": "Drach",
                                "ce:indexed-name": "Drach J."
                            },
                            "@seq": "1",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Drach",
                            "@auid": "55983174000",
                            "ce:indexed-name": "Drach J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082502",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": {"$": "Sun Yat-sen University Cancer Center"},
                            "affiliation-id": {"@afid": "60082502"},
                            "state": "Guangdong"
                        },
                        "author": [{
                            "ce:given-name": "Huiqiang",
                            "preferred-name": {
                                "ce:given-name": "Huiqiang",
                                "ce:initials": "H.",
                                "ce:surname": "Huang",
                                "ce:indexed-name": "Huang H."
                            },
                            "@seq": "2",
                            "ce:initials": "H.",
                            "@date-locked": "2018-07-21T15:39:15.101",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Huang",
                            "@auid": "34770855600",
                            "ce:indexed-name": "Huang H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Russian Federation",
                            "@afid": "60008673",
                            "@country": "rus",
                            "city": "Nizhniy Novgorod",
                            "organization": {"$": "Nizhniy Novgorod Region Clinical Hospital"},
                            "affiliation-id": {"@afid": "60008673"}
                        },
                        "author": [{
                            "ce:given-name": "Olga",
                            "preferred-name": {
                                "ce:given-name": "Olga",
                                "ce:initials": "O.",
                                "ce:surname": "Samoilova",
                                "ce:indexed-name": "Samoilova O."
                            },
                            "@seq": "3",
                            "ce:initials": "O.",
                            "@date-locked": "2021-10-28T13:49:30.948",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Samoilova",
                            "@auid": "8649039600",
                            "ce:indexed-name": "Samoilova O."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60030835",
                            "@country": "can",
                            "city": "Edmonton",
                            "organization": [
                                {"$": "University of Alberta"},
                                {"$": "Cross Cancer Institute"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60030835"},
                                {"@afid": "60020048"}
                            ],
                            "state": "AB"
                        },
                        "author": [{
                            "ce:given-name": "Andrew",
                            "preferred-name": {
                                "ce:given-name": "Andrew",
                                "ce:initials": "A.",
                                "ce:surname": "Belch",
                                "ce:indexed-name": "Belch A."
                            },
                            "@seq": "4",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Belch",
                            "@auid": "7006205753",
                            "ce:indexed-name": "Belch A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "100712314",
                            "@country": "usa",
                            "city": "Morristown",
                            "organization": {"$": "Carol G. Simon Cancer Center"},
                            "affiliation-id": {"@afid": "100712314"},
                            "state": "NJ"
                        },
                        "author": [{
                            "ce:given-name": "Charles",
                            "preferred-name": {
                                "ce:given-name": "Charles",
                                "ce:initials": "C.",
                                "ce:surname": "Farber",
                                "ce:indexed-name": "Farber C."
                            },
                            "@seq": "5",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Farber",
                            "@auid": "7007042586",
                            "ce:indexed-name": "Farber C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Belgium",
                            "@afid": "60070063",
                            "@country": "bel",
                            "city": "Yvoir",
                            "organization": {"$": "CHU Dinant-Godinne UCL Namur"},
                            "affiliation-id": {"@afid": "60070063"}
                        },
                        "author": [{
                            "ce:given-name": "André",
                            "preferred-name": {
                                "ce:given-name": "André",
                                "ce:initials": "A.",
                                "ce:surname": "Bosly",
                                "ce:indexed-name": "Bosly A."
                            },
                            "@seq": "6",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Bosly",
                            "@auid": "7005550100",
                            "ce:indexed-name": "Bosly A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Czech Republic",
                            "@afid": "60016605",
                            "@country": "cze",
                            "city": "Prague",
                            "organization": {"$": "Charles University in Prague"},
                            "affiliation-id": {"@afid": "60016605"}
                        },
                        "author": [{
                            "ce:given-name": "Jan",
                            "preferred-name": {
                                "ce:given-name": "Jan",
                                "ce:initials": "J.",
                                "ce:surname": "Novak",
                                "ce:indexed-name": "Novak J."
                            },
                            "@seq": "7",
                            "ce:initials": "J.",
                            "@date-locked": "2018-09-12T07:43:12.025",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Novak",
                            "@auid": "56651662400",
                            "ce:indexed-name": "Novak J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Poland",
                            "@afid": "60012383",
                            "@country": "pol",
                            "city": "Gdynia",
                            "organization": {"$": "Gdynia Oncology Center & Medical University of Gdansk"},
                            "affiliation-id": {"@afid": "60012383"}
                        },
                        "author": [{
                            "ce:given-name": "Jan",
                            "preferred-name": {
                                "ce:given-name": "Jan",
                                "ce:initials": "J.",
                                "ce:surname": "Zaucha",
                                "ce:indexed-name": "Zaucha J."
                            },
                            "@seq": "8",
                            "ce:initials": "J.",
                            "@date-locked": "2019-01-28T19:57:49.361",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zaucha",
                            "@auid": "55903110900",
                            "ce:indexed-name": "Zaucha J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Romania",
                            "@country": "rou",
                            "city": "Judetul, lasi",
                            "organization": {"$": "Institutul Regional de Oncologie Iasi"}
                        },
                        "author": [{
                            "ce:given-name": "Angela",
                            "preferred-name": {
                                "ce:given-name": "Angela",
                                "ce:initials": "A.",
                                "ce:surname": "Dascalescu",
                                "ce:indexed-name": "Dascalescu A."
                            },
                            "@seq": "9",
                            "ce:initials": "A.",
                            "@date-locked": "2021-04-15T13:51:49.893",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Dascalescu",
                            "@auid": "6504615748",
                            "ce:indexed-name": "Dascalescu A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60028190"},
                                {"@afid": "60022183"}
                            ]
                        },
                        "author": [{
                            "ce:given-name": "Udomsak",
                            "preferred-name": {
                                "ce:given-name": "Udomsak",
                                "ce:initials": "U.",
                                "ce:surname": "Bunworasate",
                                "ce:indexed-name": "Bunworasate U."
                            },
                            "@seq": "10",
                            "ce:initials": "U.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Bunworasate",
                            "@auid": "6507403499",
                            "ce:indexed-name": "Bunworasate U."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Ukraine",
                            "@afid": "60275210",
                            "@date-locked": "2022-12-16T05:05:20.450",
                            "@country": "ukr",
                            "city": "Lviv",
                            "organization": {"$": "Institute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine"},
                            "affiliation-id": {"@afid": "60275210"}
                        },
                        "author": [{
                            "ce:given-name": "Zvenyslava",
                            "preferred-name": {
                                "ce:given-name": "Zvenyslava",
                                "ce:initials": "Z.",
                                "ce:surname": "Masliak",
                                "ce:indexed-name": "Masliak Z."
                            },
                            "@seq": "11",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Masliak",
                            "@auid": "19636304400",
                            "ce:indexed-name": "Masliak Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Ukraine",
                            "@afid": "120143490",
                            "@country": "ukr",
                            "city": "Donetsk",
                            "organization": {"$": "Institute of Urgent and Recovery Surgery n.a V.K. Gusaka of AMS of Ukraine"},
                            "affiliation-id": {"@afid": "120143490"}
                        },
                        "author": [{
                            "ce:given-name": "Kateryna",
                            "preferred-name": {
                                "ce:given-name": "Kateryna",
                                "ce:initials": "K.",
                                "ce:surname": "Vilchevskaya",
                                "ce:indexed-name": "Vilchevskaya K."
                            },
                            "@seq": "12",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Vilchevskaya",
                            "@auid": "57200391763",
                            "ce:indexed-name": "Vilchevskaya K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Poland",
                            "@afid": "60006651",
                            "@country": "pol",
                            "city": "Lodz",
                            "organization": [
                                {"$": "Medical University of Lodz"},
                                {"$": "Copernicus Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60006651"},
                                {"@afid": "60072260"}
                            ]
                        },
                        "author": [{
                            "ce:given-name": "Tadeusz",
                            "preferred-name": {
                                "ce:given-name": "Tadeusz",
                                "ce:initials": "T.",
                                "ce:surname": "Robak",
                                "ce:indexed-name": "Robak T."
                            },
                            "@seq": "13",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Robak",
                            "@auid": "36048852000",
                            "ce:indexed-name": "Robak T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60027736",
                            "@date-locked": "2023-07-03T08:50:30.125",
                            "@country": "usa",
                            "city": "Raritan",
                            "organization": [
                                {"$": "Janssen Research & Development"},
                                {"$": "LLC"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60027736"},
                                {"@afid": "60072269"}
                            ],
                            "state": "NJ"
                        },
                        "author": [{
                            "ce:given-name": "Lixia",
                            "preferred-name": {
                                "ce:given-name": "Lixia",
                                "ce:initials": "L.",
                                "ce:surname": "Pei",
                                "ce:indexed-name": "Pei L."
                            },
                            "@seq": "14",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pei",
                            "@auid": "57203211790",
                            "ce:indexed-name": "Pei L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United Kingdom",
                            "@afid": "60072269",
                            "@country": "gbr",
                            "city": "High Wycombe",
                            "organization": {"$": "Janssen Research & Development"},
                            "affiliation-id": {"@afid": "60072269"}
                        },
                        "author": [{
                            "ce:given-name": "Brendan",
                            "preferred-name": {
                                "ce:given-name": "Brendan",
                                "ce:initials": "B.",
                                "ce:surname": "Rooney",
                                "ce:indexed-name": "Rooney B."
                            },
                            "@seq": "15",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rooney",
                            "@auid": "56544211100",
                            "ce:indexed-name": "Rooney B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60027316",
                            "@country": "usa",
                            "city": "Boston",
                            "organization": [
                                {"$": "Millennium Pharmaceuticals"},
                                {"$": "Inc."}
                            ],
                            "affiliation-id": {"@afid": "60027316"},
                            "state": "MA"
                        },
                        "author": [{
                            "ce:given-name": "Helgi",
                            "preferred-name": {
                                "ce:given-name": "Helgi",
                                "ce:initials": "H.",
                                "ce:surname": "van de Velde",
                                "ce:indexed-name": "van de Velde H."
                            },
                            "@seq": "16",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "van de Velde",
                            "@auid": "7004644771",
                            "ce:indexed-name": "van de Velde H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60033277",
                            "@country": "che",
                            "city": "Bellinzona",
                            "organization": {"$": "Oncology Institute of Southern Switzerland Ospedale San Giovanni"},
                            "affiliation-id": [
                                {"@afid": "60033277"},
                                {"@afid": "60024217"}
                            ]
                        },
                        "author": [{
                            "ce:given-name": "Franco",
                            "preferred-name": {
                                "ce:given-name": "Franco",
                                "ce:initials": "F.",
                                "ce:surname": "Cavalli",
                                "ce:indexed-name": "Cavalli F."
                            },
                            "@seq": "17",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cavalli",
                            "@auid": "57191532816",
                            "ce:indexed-name": "Cavalli F."
                        }]
                    }
                ],
                "citation-title": "Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study",
                "abstracts": "© 2017 The Author(s).This post-hoc subanalysis of the LYM-3002 phase 3 study assessed the efficacy and safety of substituting vincristine in rituximab, cyclophosphamide, doxorubicin and prednisone (R-CHOP; n=42) for bortezomib (VR-CAP; n=38) in a subgroup of 80 mantle cell lymphoma (MCL) patients aged<60 years who did not receive stem cell transplantation (SCT) despite medical eligibility. Complete response (CR)/unconfirmed CR (CRu) rates were 67 vs. 39% (odds ratio 3.69 [95% CI(confidence interval): 1.31, 10.41]; p=.012). After 40 months median follow-up, median progression-free survival by independent radiology committee with VR-CAP vs. R-CHOP was 32.6 vs. 12.0 months (hazard ratio (HR) 0.59 [95% CI: 0.31, 1.13]; p=.108); median overall survival was not reached vs. 47.3 months (HR 0.81 [95% CI: 0.33, 1.96]; p=.634). Adverse events included neutropenia (92/76%), thrombocytopenia (70/10%) and leukopenia (65/50%). VR-CAP represents a potential alternative to R-CHOP in combined and/or alternating regimens for younger, SCT-eligible MCL patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "Austria",
                        "address-part": "Währinger Gürtel 18-20",
                        "postal-code": "A-1090",
                        "@country": "aut",
                        "city": "Vienna",
                        "organization": [
                            {"$": "Medical University of Vienna"},
                            {"$": "Vienna General Hospital"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Johannes",
                        "ce:initials": "J.",
                        "ce:surname": "Drach",
                        "ce:indexed-name": "Drach J."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Bortezomib",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Frontline",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Mantle cell lymphoma",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Phase 3",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "codencode": "LELYE",
                    "sourcetitle-abbrev": "Leuk. Lymphoma",
                    "@country": "gbr",
                    "translated-sourcetitle": {
                        "$": "Leukemia and Lymphoma",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "10292403",
                            "@type": "electronic"
                        },
                        {
                            "$": "10428194",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "59",
                            "@issue": "4"
                        },
                        "pagerange": {
                            "@first": "896",
                            "@last": "903"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2018"},
                    "publisher": {"publishername": "Taylor and Francis Ltd"},
                    "sourcetitle": "Leukemia and Lymphoma",
                    "@srcid": "26016",
                    "publicationdate": {
                        "month": "09",
                        "year": "2018",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 September 2018"
                        },
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": [
                                {
                                    "classification-code": "86.6.4",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; TRANSPLANTATION IMMUNOLOGY; Transplantation"
                                },
                                {
                                    "classification-code": "86.9.1.2",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; TUMOUR IMMUNOLOGY; Neoplasia of Immune System; Human studies"
                                },
                                {
                                    "classification-code": "86.9.3.8",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; TUMOUR IMMUNOLOGY; Tumour Immunotherapy; Monoclonal antibodies - therapeutic applications"
                                },
                                {
                                    "classification-code": "87.4.1.12",
                                    "classification-description": "CANCER RESEARCH; TREATMENT; Chemotherapy; Drug combinations"
                                },
                                {
                                    "classification-code": "87.4.3.8",
                                    "classification-description": "CANCER RESEARCH; TREATMENT; Immunotherapy; Monoclonal antibodies - therapeutic applications"
                                },
                                {
                                    "classification-code": "87.5.26.4",
                                    "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Haematologic Malignancies; Other lymphomas"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2720"},
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "179324-69-7"},
                                        {"$": "197730-97-5"}
                                    ],
                                    "chemical-name": "bortezomib"
                                },
                                {
                                    "cas-registry-number": "50-18-0",
                                    "chemical-name": "cyclophosphamide"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "23214-92-8"},
                                        {"$": "25316-40-9"}
                                    ],
                                    "chemical-name": "doxorubicin"
                                },
                                {
                                    "cas-registry-number": "53-03-2",
                                    "chemical-name": "prednisone"
                                },
                                {
                                    "cas-registry-number": "174722-31-7",
                                    "chemical-name": "rituximab"
                                },
                                {
                                    "cas-registry-number": "57-22-7",
                                    "chemical-name": "vincristine"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antibodies, Monoclonal, Murine-Derived"},
                                {"chemical-name": "Bortezomib"},
                                {"chemical-name": "Cyclophosphamide"},
                                {"chemical-name": "Doxorubicin"},
                                {"chemical-name": "Prednisone"},
                                {"chemical-name": "R-CHOP protocol"},
                                {"chemical-name": "Rituximab"},
                                {"chemical-name": "Vincristine"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This work was supported by Janssen Research and Development, LLC and co-funded by Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-acronym": "JRD",
                        "grant-agency": {
                            "@iso-code": "usa",
                            "$": "Janssen Research and Development"
                        },
                        "grant-agency-id": "100005205"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2019 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Process",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "21",
                    "@year": "2019",
                    "@timestamp": "BST 18:05:25",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "620388079",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "2018024677",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "907945430",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20180057943",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "29338540",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20180146931",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20180192473",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85041097046",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85041097046",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "625992493",
                            "@idtype": "PUIsecondary"
                        }
                    ],
                    "ce:doi": "10.1080/10428194.2017.1365855"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "24",
                "reference": [
                    {
                        "ref-fulltext": "Herrmann A, Hoster E, Zwingers T, et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol. 2009;27:511-518.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Improvement of overall survival in advanced stage mantle cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "59149105528",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "511",
                                    "@last": "518"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Herrmann",
                                        "ce:indexed-name": "Herrmann A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hoster",
                                        "ce:indexed-name": "Hoster E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Zwingers",
                                        "ce:indexed-name": "Zwingers T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Vose JM. Mantle cell lymphoma: 2013 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2013;88:1082-1088.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Mantle cell lymphoma: 2013 update on diagnosis, risk-stratification, and clinical management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84888029681",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "88"},
                                "pagerange": {
                                    "@first": "1082",
                                    "@last": "1088"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "J.M.",
                                "@_fa": "true",
                                "ce:surname": "Vose",
                                "ce:indexed-name": "Vose J.M."
                            }]},
                            "ref-sourcetitle": "Am J Hematol"
                        }
                    },
                    {
                        "ref-fulltext": "Williams ME. Transplantation for mantle cell lymphoma: is it the right thing to do? Hematology Am Soc Hematol Educ Program. 2013;2013:568-574.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Transplantation for mantle cell lymphoma: Is it the right thing to do?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84904523445",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2013"},
                                "pagerange": {
                                    "@first": "568",
                                    "@last": "574"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "M.E.",
                                "@_fa": "true",
                                "ce:surname": "Williams",
                                "ce:indexed-name": "Williams M.E."
                            }]},
                            "ref-sourcetitle": "Hematology am Soc Hematol Educ Program"
                        }
                    },
                    {
                        "ref-fulltext": "Dreyling M, Geisler C, Hermine O, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014; 25:383-392.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84911469440",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "383",
                                    "@last": "392"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Dreyling",
                                        "ce:indexed-name": "Dreyling M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Geisler",
                                        "ce:indexed-name": "Geisler C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Hermine",
                                        "ce:indexed-name": "Hermine O."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesVR): B-cell Lymphomas. Version 3.2017; March 27, 2017. [cited 2017 Jun 23]. Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85022205134",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Version 3.2017; March 27",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Comprehensive Cancer Network (NCCN)",
                                "ce:indexed-name": "National Comprehensive Cancer Network (NCCN)"
                            }},
                            "ref-sourcetitle": "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelinesvr): B-Cell Lymphomas"
                        }
                    },
                    {
                        "ref-fulltext": "Pham LV, Tamayo AT, Yoshimura LC, et al. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol. 2003;171:88-95.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0038206722",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "171"},
                                "pagerange": {
                                    "@first": "88",
                                    "@last": "95"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Pham",
                                        "ce:indexed-name": "Pham L.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Tamayo",
                                        "ce:indexed-name": "Tamayo A.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshimura",
                                        "ce:indexed-name": "Yoshimura L.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunol"
                        }
                    },
                    {
                        "ref-fulltext": "Chiarle R, Budel LM, Skolnik J, et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood. 2000;95:619-626.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "12944283204",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "95"},
                                "pagerange": {
                                    "@first": "619",
                                    "@last": "626"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiarle",
                                        "ce:indexed-name": "Chiarle R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Budel",
                                        "ce:indexed-name": "Budel L.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Skolnik",
                                        "ce:indexed-name": "Skolnik J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        }
                    },
                    {
                        "ref-fulltext": "Millennium Pharmaceuticals Inc. VELCADEVR (bortezomib) for injection: for subcutaneous or intravenous use, full prescribing information. Version 19; June, 2017. [cited 2017 Jun 23]. Available from: http://www.velcade.com/files/pdfs/velcade_prescribing_information.pdf",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.velcade.com/files/pdfs/velcade_prescribing_information.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046841093",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Version 19; June",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Millennium Pharmaceuticals Inc",
                                "ce:indexed-name": "Millennium Pharmaceuticals Inc"
                            }},
                            "ref-sourcetitle": "VELCADEVR (Bortezomib) For Injection: For Subcutaneous Or Intravenous Use, Full Prescribing Information"
                        }
                    },
                    {
                        "ref-fulltext": "Velcade. Summary of Product Characteristics. Last updated 10 March, 2017. [cited 2017 Jun 23]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000539/WC500048471.pdf",
                        "@id": "9",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000539/WC500048471.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "77952118055",
                                "@idtype": "SGR"
                            }},
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Velcade",
                                "ce:indexed-name": "Velcade"
                            }},
                            "ref-sourcetitle": "Summary of Product Characteristics"
                        }
                    },
                    {
                        "ref-fulltext": "Perez-Galan P, Roue G, Villamor N, et al. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood. 2006;107:257-264.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status"},
                            "refd-itemidlist": {"itemid": {
                                "$": "30144442233",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "107"},
                                "pagerange": {
                                    "@first": "257",
                                    "@last": "264"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Perez-Galan",
                                        "ce:indexed-name": "Perez-Galan P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Roue",
                                        "ce:indexed-name": "Roue G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Villamor",
                                        "ce:indexed-name": "Villamor N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        }
                    },
                    {
                        "ref-fulltext": "Robak T, Huang H, Jin J, et al. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. N Engl J Med. 2015;372:944-953.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84924439988",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "372"},
                                "pagerange": {
                                    "@first": "944",
                                    "@last": "953"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Robak",
                                        "ce:indexed-name": "Robak T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jin",
                                        "ce:indexed-name": "Jin J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        }
                    },
                    {
                        "ref-fulltext": "Giebel S, Labopin M, Ehninger G, et al. Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. Blood. 2010;116: 122-128",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77955945641",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "116"},
                                "pagerange": {
                                    "@first": "122",
                                    "@last": "128"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Giebel",
                                        "ce:indexed-name": "Giebel S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Labopin",
                                        "ce:indexed-name": "Labopin M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Ehninger",
                                        "ce:indexed-name": "Ehninger G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        }
                    },
                    {
                        "ref-fulltext": "Passweg JR, Baldomero H, Bader P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51:786-792.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84959116459",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "51"},
                                "pagerange": {
                                    "@first": "786",
                                    "@last": "792"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Passweg",
                                        "ce:indexed-name": "Passweg J.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Baldomero",
                                        "ce:indexed-name": "Baldomero H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Bader",
                                        "ce:indexed-name": "Bader P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Bone Marrow Transplant"
                        }
                    },
                    {
                        "ref-fulltext": "Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579-586.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Revised response criteria for malignant lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33947496614",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "579",
                                    "@last": "586"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheson",
                                        "ce:indexed-name": "Cheson B.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Pfistner",
                                        "ce:indexed-name": "Pfistner B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Juweid",
                                        "ce:indexed-name": "Juweid M.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Flinn IW, van der Jagt R, Kahl BS, et al. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood. 2014;123:2944-2952.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: The BRIGHT study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84900423736",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "123"},
                                "pagerange": {
                                    "@first": "2944",
                                    "@last": "2952"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Flinn",
                                        "ce:indexed-name": "Flinn I.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Der Jagt",
                                        "ce:indexed-name": "Van Der Jagt R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kahl",
                                        "ce:indexed-name": "Kahl B.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        }
                    },
                    {
                        "ref-fulltext": "Visco C, Finotto S, Zambello R, et al. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. J Clin Oncol. 2013;31:1442-1449.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84875606235",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "1442",
                                    "@last": "1449"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Visco",
                                        "ce:indexed-name": "Visco C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Finotto",
                                        "ce:indexed-name": "Finotto S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Zambello",
                                        "ce:indexed-name": "Zambello R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Inwards DJ, Fishkin PA, Hillman DW, et al. Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group. Cancer. 2008;113:108-116.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group"},
                            "refd-itemidlist": {"itemid": {
                                "$": "47249112184",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "113"},
                                "pagerange": {
                                    "@first": "108",
                                    "@last": "116"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Inwards",
                                        "ce:indexed-name": "Inwards D.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Fishkin",
                                        "ce:indexed-name": "Fishkin P.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Hillman",
                                        "ce:indexed-name": "Hillman D.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "Spurgeon SE, Pindyck T, Okada C, et al. Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. Leuk Lymphoma. 2011;52:1488-1494.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79960400013",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {
                                    "@first": "1488",
                                    "@last": "1494"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Spurgeon",
                                        "ce:indexed-name": "Spurgeon S.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Pindyck",
                                        "ce:indexed-name": "Pindyck T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Okada",
                                        "ce:indexed-name": "Okada C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leuk Lymphoma"
                        }
                    },
                    {
                        "ref-fulltext": "Ruan J, Martin P, Shah B, et al. Lenalidomide plus rituximab as initial treatment for mantle-cell lymphoma. N Engl J Med. 2015;373:1835-1844.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Lenalidomide plus rituximab as initial treatment for mantle-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84946616176",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "1835",
                                    "@last": "1844"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ruan",
                                        "ce:indexed-name": "Ruan J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        }
                    },
                    {
                        "ref-fulltext": "Fisher RI, Bernstein SH, Kahl BS, et al. Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol. 2006;24:4867-4874.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33750625445",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "4867",
                                    "@last": "4874"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Fisher",
                                        "ce:indexed-name": "Fisher R.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Bernstein",
                                        "ce:indexed-name": "Bernstein S.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kahl",
                                        "ce:indexed-name": "Kahl B.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Goy A, Bernstein SH, Kahl BS, et al. Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Ann Oncol. 2009; 20:520-525.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Bortezomib in patients with relapsed or refractory mantle cell lymphoma: Updated time-to-event analyses of the multicenter phase 2 PINNACLE study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "61649094981",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "520",
                                    "@last": "525"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Goy",
                                        "ce:indexed-name": "Goy A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Bernstein",
                                        "ce:indexed-name": "Bernstein S.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kahl",
                                        "ce:indexed-name": "Kahl B.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Kane RC, Dagher R, Farrell A, et al. Bortezomib for the treatment of mantle cell lymphoma. Clin Cancer Res. 2007;13:5291-5294.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Bortezomib for the treatment of mantle cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34848870352",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "5291",
                                    "@last": "5294"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Kane",
                                        "ce:indexed-name": "Kane R.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Dagher",
                                        "ce:indexed-name": "Dagher R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Farrell",
                                        "ce:indexed-name": "Farrell A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        }
                    },
                    {
                        "ref-fulltext": "Romaguera JE, Fayad LE, McLaughlin P, et al. Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma. Br J Haematol. 2010;151:47-53.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77956853122",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "151"},
                                "pagerange": {
                                    "@first": "47",
                                    "@last": "53"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Romaguera",
                                        "ce:indexed-name": "Romaguera J.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Fayad",
                                        "ce:indexed-name": "Fayad L.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "McLaughlin",
                                        "ce:indexed-name": "McLaughlin P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        }
                    },
                    {
                        "ref-fulltext": "Chang JE, Li H, Smith MR, et al. Phase 2 study of VcRCVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405). Blood. 2014;123:1665-1673.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Phase 2 study of VcRCVAD with maintenance rituximab for untreated mantle cell lymphoma: An Eastern Cooperative Oncology Group study (E1405)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84897521309",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "123"},
                                "pagerange": {
                                    "@first": "1665",
                                    "@last": "1673"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Chang",
                                        "ce:indexed-name": "Chang J.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith M.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        }
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Lviv",
            "@id": "60275210",
            "affilname": "State Institution «Institute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine»",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60275210",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60082502",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beerse",
            "@id": "60072269",
            "affilname": "Janssen Research &amp; Development",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072269",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Dinant",
            "@id": "60070063",
            "affilname": "CHU Dinant Godinne | UCL Namur",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070063",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Bellinzona",
            "@id": "60033277",
            "affilname": "Oncology Institute of Southern Switzerland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033277",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Edmonton",
            "@id": "60030835",
            "affilname": "University of Alberta",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030835",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Titusville",
            "@id": "60027736",
            "affilname": "Janssen Pharmaceuticals, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027736",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "60027316",
            "affilname": "Takeda Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027316",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Prague",
            "@id": "60016605",
            "affilname": "Charles University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Gdańsk",
            "@id": "60012383",
            "affilname": "Gdanski Uniwersytet Medyczny",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012383",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60011394",
            "affilname": "Medizinische Universität Wien",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011394",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Nizhny Novgorod",
            "@id": "60008673",
            "affilname": "Lobachevsky State University of Nizhni Novgorod",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008673",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Lodz",
            "@id": "60006651",
            "affilname": "Medical University of Lodz",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006651",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Donetsk",
            "@id": "120143490",
            "affilname": "Institute of Urgent and Recovery Surgery n.a V.K. Gusaka of AMS of Ukraine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120143490",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Morristown",
            "@id": "100712314",
            "affilname": "Carol G. Simon Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100712314",
            "affiliation-country": "United States"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85041097046",
        "dc:description": "This post-hoc subanalysis of the LYM-3002 phase 3 study assessed the efficacy and safety of substituting vincristine in rituximab, cyclophosphamide, doxorubicin and prednisone (R-CHOP; n=42) for bortezomib (VR-CAP; n=38) in a subgroup of 80 mantle cell lymphoma (MCL) patients aged<60 years who did not receive stem cell transplantation (SCT) despite medical eligibility. Complete response (CR)/unconfirmed CR (CRu) rates were 67 vs. 39% (odds ratio 3.69 [95% CI(confidence interval): 1.31, 10.41]; p=.012). After 40 months median follow-up, median progression-free survival by independent radiology committee with VR-CAP vs. R-CHOP was 32.6 vs. 12.0 months (hazard ratio (HR) 0.59 [95% CI: 0.31, 1.13]; p=.108); median overall survival was not reached vs. 47.3 months (HR 0.81 [95% CI: 0.33, 1.96]; p=.634). Adverse events included neutropenia (92/76%), thrombocytopenia (70/10%) and leukopenia (65/50%). VR-CAP represents a potential alternative to R-CHOP in combined and/or alternating regimens for younger, SCT-eligible MCL patients.",
        "pubmed-id": "29338540",
        "prism:coverDate": "2018-09-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85041097046",
        "dc:creator": {"author": [{
            "ce:given-name": "Johannes",
            "preferred-name": {
                "ce:given-name": "Johannes",
                "ce:initials": "J.",
                "ce:surname": "Drach",
                "ce:indexed-name": "Drach J."
            },
            "@seq": "1",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011394",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011394"
            },
            "ce:surname": "Drach",
            "@auid": "55983174000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55983174000",
            "ce:indexed-name": "Drach J."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85041097046"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041097046&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85041097046&origin=inward"
            }
        ],
        "source-id": "26016",
        "citedby-count": "14",
        "prism:volume": "59",
        "subtype": "ar",
        "dc:title": "Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study",
        "openaccess": "1",
        "prism:issn": "10292403 10428194",
        "publishercopyright": "© 2017 The Author(s).",
        "prism:issueIdentifier": "4",
        "subtypeDescription": "Article",
        "prism:publicationName": "Leukemia and Lymphoma",
        "prism:pageRange": "896-903",
        "prism:endingPage": "903",
        "openaccessFlag": "true",
        "prism:doi": "10.1080/10428194.2017.1365855",
        "prism:startingPage": "896",
        "dc:identifier": "SCOPUS_ID:85041097046",
        "dc:publisher": "Taylor and Francis Ltd"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Age Factors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antibodies, Monoclonal, Murine-Derived",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Combined Chemotherapy Protocols",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Bortezomib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cyclophosphamide",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Doxorubicin",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Follow-Up Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Leukopenia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lymphoma, Mantle-Cell",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Neutropenia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Practice Guidelines as Topic",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prednisone",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Progression-Free Survival",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Rituximab",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Stem Cell Transplantation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thrombocytopenia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Vincristine",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Bortezomib"
        },
        {
            "@_fa": "true",
            "$": "Frontline"
        },
        {
            "@_fa": "true",
            "$": "Mantle cell lymphoma"
        },
        {
            "@_fa": "true",
            "$": "Phase 3"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Johannes",
            "preferred-name": {
                "ce:given-name": "Johannes",
                "ce:initials": "J.",
                "ce:surname": "Drach",
                "ce:indexed-name": "Drach J."
            },
            "@seq": "1",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011394",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011394"
            },
            "ce:surname": "Drach",
            "@auid": "55983174000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55983174000",
            "ce:indexed-name": "Drach J."
        },
        {
            "ce:given-name": "Huiqiang",
            "preferred-name": {
                "ce:given-name": "Huiqiang",
                "ce:initials": "H.",
                "ce:surname": "Huang",
                "ce:indexed-name": "Huang H."
            },
            "@seq": "2",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082502",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502"
            },
            "ce:surname": "Huang",
            "@auid": "34770855600",
            "author-url": "https://api.elsevier.com/content/author/author_id/34770855600",
            "ce:indexed-name": "Huang H."
        },
        {
            "ce:given-name": "Olga",
            "preferred-name": {
                "ce:given-name": "Olga",
                "ce:initials": "O.",
                "ce:surname": "Samoilova",
                "ce:indexed-name": "Samoilova O."
            },
            "@seq": "3",
            "ce:initials": "O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008673",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008673"
            },
            "ce:surname": "Samoilova",
            "@auid": "8649039600",
            "author-url": "https://api.elsevier.com/content/author/author_id/8649039600",
            "ce:indexed-name": "Samoilova O."
        },
        {
            "ce:given-name": "Andrew",
            "preferred-name": {
                "ce:given-name": "Andrew",
                "ce:initials": "A.",
                "ce:surname": "Belch",
                "ce:indexed-name": "Belch A."
            },
            "@seq": "4",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60030835",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030835"
            },
            "ce:surname": "Belch",
            "@auid": "7006205753",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006205753",
            "ce:indexed-name": "Belch A."
        },
        {
            "ce:given-name": "Charles",
            "preferred-name": {
                "ce:given-name": "Charles",
                "ce:initials": "C.",
                "ce:surname": "Farber",
                "ce:indexed-name": "Farber C."
            },
            "@seq": "5",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "100712314",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100712314"
            },
            "ce:surname": "Farber",
            "@auid": "7007042586",
            "author-url": "https://api.elsevier.com/content/author/author_id/7007042586",
            "ce:indexed-name": "Farber C."
        },
        {
            "ce:given-name": "André",
            "preferred-name": {
                "ce:given-name": "André",
                "ce:initials": "A.",
                "ce:surname": "Bosly",
                "ce:indexed-name": "Bosly A."
            },
            "@seq": "6",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60070063",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070063"
            },
            "ce:surname": "Bosly",
            "@auid": "7005550100",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005550100",
            "ce:indexed-name": "Bosly A."
        },
        {
            "ce:given-name": "Jan",
            "preferred-name": {
                "ce:given-name": "Jan",
                "ce:initials": "J.",
                "ce:surname": "Novak",
                "ce:indexed-name": "Novak J."
            },
            "@seq": "7",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016605",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605"
            },
            "ce:surname": "Novak",
            "@auid": "56651662400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56651662400",
            "ce:indexed-name": "Novak J."
        },
        {
            "ce:given-name": "Jan",
            "preferred-name": {
                "ce:given-name": "Jan",
                "ce:initials": "J.",
                "ce:surname": "Zaucha",
                "ce:indexed-name": "Zaucha J."
            },
            "@seq": "8",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012383",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012383"
            },
            "ce:surname": "Zaucha",
            "@auid": "55903110900",
            "author-url": "https://api.elsevier.com/content/author/author_id/55903110900",
            "ce:indexed-name": "Zaucha J."
        },
        {
            "ce:given-name": "Angela",
            "preferred-name": {
                "ce:given-name": "Angela",
                "ce:initials": "A.",
                "ce:surname": "Dascalescu",
                "ce:indexed-name": "Dascalescu A."
            },
            "@seq": "9",
            "ce:initials": "A.",
            "@_fa": "true",
            "ce:surname": "Dascalescu",
            "@auid": "6504615748",
            "author-url": "https://api.elsevier.com/content/author/author_id/6504615748",
            "ce:indexed-name": "Dascalescu A."
        },
        {
            "ce:given-name": "Udomsak",
            "preferred-name": {
                "ce:given-name": "Udomsak",
                "ce:initials": "U.",
                "ce:surname": "Bunworasate",
                "ce:indexed-name": "Bunworasate U."
            },
            "@seq": "10",
            "ce:initials": "U.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Bunworasate",
            "@auid": "6507403499",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507403499",
            "ce:indexed-name": "Bunworasate U."
        },
        {
            "ce:given-name": "Zvenyslava",
            "preferred-name": {
                "ce:given-name": "Zvenyslava",
                "ce:initials": "Z.",
                "ce:surname": "Masliak",
                "ce:indexed-name": "Masliak Z."
            },
            "@seq": "11",
            "ce:initials": "Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60275210",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60275210"
            },
            "ce:surname": "Masliak",
            "@auid": "19636304400",
            "author-url": "https://api.elsevier.com/content/author/author_id/19636304400",
            "ce:indexed-name": "Masliak Z."
        },
        {
            "ce:given-name": "Kateryna",
            "preferred-name": {
                "ce:given-name": "Kateryna",
                "ce:initials": "K.",
                "ce:surname": "Vilchevskaya",
                "ce:indexed-name": "Vilchevskaya K."
            },
            "@seq": "12",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "120143490",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120143490"
            },
            "ce:surname": "Vilchevskaya",
            "@auid": "57200391763",
            "author-url": "https://api.elsevier.com/content/author/author_id/57200391763",
            "ce:indexed-name": "Vilchevskaya K."
        },
        {
            "ce:given-name": "Tadeusz",
            "preferred-name": {
                "ce:given-name": "Tadeusz",
                "ce:initials": "T.",
                "ce:surname": "Robak",
                "ce:indexed-name": "Robak T."
            },
            "@seq": "13",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006651",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006651"
            },
            "ce:surname": "Robak",
            "@auid": "36048852000",
            "author-url": "https://api.elsevier.com/content/author/author_id/36048852000",
            "ce:indexed-name": "Robak T."
        },
        {
            "ce:given-name": "Lixia",
            "preferred-name": {
                "ce:given-name": "Lixia",
                "ce:initials": "L.",
                "ce:surname": "Pei",
                "ce:indexed-name": "Pei L."
            },
            "@seq": "14",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027736",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027736"
            },
            "ce:surname": "Pei",
            "@auid": "57203211790",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203211790",
            "ce:indexed-name": "Pei L."
        },
        {
            "ce:given-name": "Brendan",
            "preferred-name": {
                "ce:given-name": "Brendan",
                "ce:initials": "B.",
                "ce:surname": "Rooney",
                "ce:indexed-name": "Rooney B."
            },
            "@seq": "15",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60072269",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072269"
            },
            "ce:surname": "Rooney",
            "@auid": "56544211100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56544211100",
            "ce:indexed-name": "Rooney B."
        },
        {
            "ce:given-name": "Helgi",
            "preferred-name": {
                "ce:given-name": "Helgi",
                "ce:initials": "H.",
                "ce:surname": "van de Velde",
                "ce:indexed-name": "van de Velde H."
            },
            "@seq": "16",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027316",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027316"
            },
            "ce:surname": "van de Velde",
            "@auid": "7004644771",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004644771",
            "ce:indexed-name": "van de Velde H."
        },
        {
            "ce:given-name": "Franco",
            "preferred-name": {
                "ce:given-name": "Franco",
                "ce:initials": "F.",
                "ce:surname": "Cavalli",
                "ce:indexed-name": "Cavalli F."
            },
            "@seq": "17",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60033277",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033277"
            },
            "ce:surname": "Cavalli",
            "@auid": "57191532816",
            "author-url": "https://api.elsevier.com/content/author/author_id/57191532816",
            "ce:indexed-name": "Cavalli F."
        }
    ]}
}}